Does biosimilar competition impact the reimbursement policy of the originator reference products? Given the excessive costs associated with biological and biosimilar drugs, the price behavior of this class of medicines is particularly important from industry and societal perspective. It is known that the availability of biosimilars can lead to rapid price reductions, particularly in markets… Czytaj dalej Does biosimilar competition impact the reimbursement policy of the originator reference products?